Paving a Path to Relief of Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Live Patient Simulations Demonstrating Innovations in Diagnosis and Treatment

Release Date: October 31, 2018
Last Reviewed: October 28, 2018
Expiration Date: October 31, 2019
Time to Complete Activity: 1.5 hours

*This activity expired for credit on October 31, 2019 and is no longer available for credit

Lin Chang, MD
Professor of Medicine
Vice-Chief, Vatche and Tamar Manounkian Division of Digestive Diseases
Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience
David Geffen School of Medicine at University of California
Los Angeles, CA
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Director, Northwestern Neuro-gastromotility and Functional Bowel Programs
Director, Motts Tonelli GI Physiology Laboratory
Northwestern University Feinberg School of Medicine
Chicago, IL
This activity is provided by Paradigm Medical Communications, LLC.
Target Audience
This activity has been designed to meet the educational needs of gastroenterology and primary care clinicians (physicians, nurse practitioners and PAs). It may also be of benefit to gynecologists, pharmacists, and other clinicians who are interested and actively engaged in the management of patients with IBS and CIC.
Statement of Need
Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are among the most commonly seen gastrointestinal disorders worldwide, and the personal impact on patients is substantial. IBS-C and IBS-D comprise a considerable proportion of the overall IBS population. Over-testing patients to diagnose either of these IBS subtypes, or CIC, to exclude other diseases is a persistent problem that is inconsistent with evidence-based guidelines and contributes to patients’ suffering, frustration, and dissatisfaction with care. Post-diagnosis, optimal management is controversial, and outcomes are variable. In addition, opportunities to improve outcomes with effective patient communication strategies are often missed. Through a carefully balanced presentation, two national-level experts in IBS and CIC management will present the latest evidence, guidelines, and patient-clinician communications strategies at key decision points using interactive case-based simulations presenting physician-patient scenarios.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Identify symptoms and pathophysiologic traits suggesting irritable bowel syndrome or chronic idiopathic constipation.
  • Select appropriate, individualized therapy for managing irritable bowel syndrome or chronic idiopathic constipation, based on current clinical data as well as patients’ disease characteristics, needs, and preferences.
  • Identify practical recommendations and resources for optimizing patient-clinician interactions and providing patient education and counseling for coping with irritable bowel syndrome subtypes or chronic idiopathic constipation and their treatment.
Table of Contents
Patient Simulations and Discussions
Q & A and Discussions
Physician Accreditation Statement
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.5 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This activity is supported by an educational grant from Allergan, Inc and Ironwood Pharmaceuticals, Inc.
Instructions for Participation
To receive a CME certificate of participation, you should:
  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Technical Support: If you have any technical problems or playback issues, email us at
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Lin Chang, MD
Advisory Board: BioAmerica Biotech; IM HealthScience; Salix Pharmaceuticals, Inc; Synergy Pharmaceuticals Inc
Grant/Research Support: Allergan, Inc; Ardelyx, Inc
Retained Consultant: metaMe Health, Modify Health
Speakers Bureau: Allergan, Inc
Darren M. Brenner, MD
Retained Consultant: Allergan, Inc/Ironwood Pharmaceuticals, Inc; Daiichi Sankyo; GI Health Foundation; Salix Pharmaceuticals; Shire; Synergy Pharmaceuticals Inc
Speakers Bureau: Allergan, Inc/Ironwood Pharmaceuticals, Inc.; Daiichi Sankyo; GI Health Foundation; Salix Pharmaceuticals; Shire; Synergy Pharmaceuticals Inc
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Patient reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC, is committed to protecting the privacy of those who participate in the activities (herein referred to as “website") located at The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.
Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at
© 2018 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.